Prognostic Value of Blood Panel Parameters in Patients With Dilated Cardiomyopathy and Advanced Heart Failure

J M Sobrino-Márquez1, A Grande-Trillo1, E M Cantero-Pérez1

  • 1Heart Failure and Heart Transplant Unit, Department of Cardiology, Hospital Universitario Virgen del Rocío, Seville, Spain.

Insights

Basic blood tests can predict outcomes in patients with dilated cardiomyopathy (DCM) and heart failure. A higher red cell distribution width (RDW) indicates increased risk of mortality or heart transplant, aiding in patient stratification.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarkers

Background:

  • Dilated cardiomyopathy (DCM) and left ventricular dysfunction present varied clinical courses.
  • Prognostic markers are crucial for stratifying patients with heart failure.
  • Left ventricular ejection fraction (LVEF) and symptoms alone do not fully predict outcomes.

Purpose of the Study:

  • To determine the prognostic value of basic blood panel parameters in patients with DCM and severe left ventricular dysfunction.
  • To identify simple blood markers for risk stratification in heart failure patients.

Main Methods:

  • Analysis of 87 patients with idiopathic or familial DCM and LVEF <30% from 2009-2011.
  • 5-year follow-up data to assess mortality and heart transplant events.
  • Evaluation of red cell distribution width (RDW) and neutrophil to lymphocyte ratio (NLR).

Main Results:

  • Patients with better outcomes had lower RDW, higher lymphocyte counts, and lower NLR.
  • An RDW ≥15% was significantly associated with increased long-term mortality or need for heart transplant.
  • No significant differences in age or sex between survival and non-survival groups.

Conclusions:

  • Basic blood panel parameters, particularly RDW, can serve as useful prognostic tools for heart failure patients.
  • A multimarker strategy may enhance patient stratification in advanced heart failure.
  • Larger studies are needed to validate these findings.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
589
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K